2-5A antisense telomerase RNA therapy for intracranial malignant gliomas

Cancer Research

Volumn 60, Issue 16, 2000, Pages 4461-4467

  Mukai, Shigehiko ^a   Kondo, Yasuko ^b   Koga, Shoji ^a   Komata, Tadashi ^a,b   Barna, Barbara P ^c   Kondo, Seiji ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE PHOSPHATE; ADENOSINE PHOSPHATE; ANTISENSE TELOMERASE RIBONUCLEIC ACID; CATION; COMPLEMENTARY RNA; LIPOSOME; RIBONUCLEASE; RNA; TELOMERASE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTE; CELL VIABILITY; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME INHIBITION; ENZYME SPECIFICITY; GENE TARGETING; GENE THERAPY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA DEGRADATION;

ADENINE NUCLEOTIDES; ANIMALS; BRAIN NEOPLASMS; CATION EXCHANGE RESINS; CATIONS; FEMALE; GLIOMA; HUMANS; LIPIDS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGORIBONUCLEOTIDES; OLIGORIBONUCLEOTIDES, ANTISENSE; RNA, NEOPLASM; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0034662616     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. National survey of patterns of care for brain-tumor patients
2. Epidemiology and factors affecting survival
3. Specific association of human telomerase activity with immortal cells and cancer
4. Telomeres and telomerase in human cancer
5. Telomerase activity in human cancer
6. Telomerase activity in human brain tumors
7. Differential telomerase expression in human primary intracranial tumors
8. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA
9. Inhibition of cell-free protein synthesis by pppA2′p5 ′A2′p5′A: A novel oligonucleotides synthesized by interferon-treated L cell extracts
10. Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action
11. Targeting RNA for degradation with a (2′-5′)oligoadenylate-antisense chimera
12. Blockage of NF-κB signaling by selective ablation of an mRNA target by 2-5A antisense chimeras
13. Targeting RNA decay with 2′, 5′ oligoadenylate-antisense in respiratory syncytial virus-infected cells
14. Cationic liposome-mediated transfection
15. Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans
16. Inhibition of human ovarian carcinoma cell proliferation by liposome-plasmid DNA complex
17. Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer
18. Improved cationic lipid formations for in vivo gene therapy
19. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation
20. Apoptosis during B lymphopoiesis in mouse bone marrow
21. Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo
22. Clinical implications of telomerase in cancer
23. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides
24. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells
25. Inhibition of human telomerase activity by peptide nucleic acids
26. Creation of human tumor cells with defined genetic elements
27. The RNA component of human telomerase
28. A mammalian telomerase-associated protein
29. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
30. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
31. Telomerase catalytic subunit homologs from fission yeast and human
32. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTR
33. Telomerase activation by hTR in human normal fibroblasts and hepatocellular carcinomas
34. Inhibition of telomerase limits the growth of human cancer cells
35. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
36. Treatment of prostate cancer in vitro and in vivo with 2-5A2-5A-anti-telomerase RNA component
37. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
38. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3
39. Ich-1, and Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death
40. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1β-converting enzyme
41. Human ICE/CED-3 protease nomenclature